» Articles » PMID: 21438939

Relative Performance of Common Biochemical Indicators in Detecting Cigarette Smoking

Overview
Journal Addiction
Specialty Psychiatry
Date 2011 Mar 29
PMID 21438939
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Many cities have banned indoor smoking in public places. Thus, an updated recommendation for a breath carbon monoxide (CO) cut-off is needed that optimally determines smoking status. We evaluated and compared the performance of breath CO and semiquantitative cotinine immunoassay test strips (urine and saliva NicAlert®) alone and in combination.

Design: Cross-sectional study.

Setting: Urban drug addiction research and treatment facility.

Participants: Ninety non-treatment-seeking smokers and 82 non-smokers.

Measurements: Participants completed smoking histories and provided breath CO, urine and saliva specimens. Urine and saliva specimens were assayed for cotinine by NicAlert® and liquid chromatography-tandem mass spectrometry (LCMSMS).

Findings: An optimal breath CO cut-off was established using self-report and LCMSMS analysis of cotinine, an objective indicator, as reference measures. Performance of smoking indicators and combinations were compared to the reference measures. Breath CO ≥5 parts per million (p.p.m.) optimally discriminated smokers from non-smokers. Saliva NicAlert® performance was less effective than the other indicators.

Conclusions: In surveys of smokers and non-smokers in areas with strong smoke-free laws, the breath carbon monoxide cut-off that discriminates most effectively appears to be ≥5 p.p.m. rather than the ≥10 p.p.m. cut-off often used. These findings may not generalize to clinical trials, regions with different carbon monoxide pollution levels or areas with less stringent smoke-free laws.

Citing Articles

Extending contingency management for smoking cessation to patients with or at risk for cardiovascular disease: A preliminary trial of a home-based intervention.

Coleman S, Higgins S, Smyth J, Rodriguez B, Loganathan M, Gaalema D Exp Clin Psychopharmacol. 2023; 32(3):270-276.

PMID: 37602999 PMC: 10879453. DOI: 10.1037/pha0000677.


Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.

Nollen N, Ahluwalia J, Mayo M, Ellerbeck E, Leavens E, Salzman G JAMA Netw Open. 2023; 6(6):e2317895.

PMID: 37338906 PMC: 10282892. DOI: 10.1001/jamanetworkopen.2023.17895.


Protocol from a randomized clinical trial of multiple pharmacotherapy adaptations based on treatment response in African Americans who smoke.

Nollen N, Cox L, Mayo M, Ellerbeck E, Arnold M, Salzman G Contemp Clin Trials Commun. 2022; 30:101032.

PMID: 36387983 PMC: 9641174. DOI: 10.1016/j.conctc.2022.101032.


Determining Optimal Cutoffs for Exhaled Carbon Monoxide and Salivary Cotinine to Identify Smokers among Korean Americans in a Smoking Cessation Clinical Trial.

Kim S, Kim S, Gona P J Smok Cessat. 2021; 2021:6678237.

PMID: 34306232 PMC: 8279201. DOI: 10.1155/2021/6678237.


Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.

Ray L, Green R, Enders C, Leventhal A, Grodin E, Li G Am J Psychiatry. 2021; 178(9):818-828.

PMID: 34080890 PMC: 8999864. DOI: 10.1176/appi.ajp.2020.20070993.


References
1.
Best D, Green E, Smith J, Perry D . Dipstick tests for secondhand smoke exposure. Nicotine Tob Res. 2010; 12(6):551-6. DOI: 10.1093/ntr/ntq043. View

2.
Etzel R . A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Prev Med. 1990; 19(2):190-7. DOI: 10.1016/0091-7435(90)90020-k. View

3.
Schepis T, Duhig A, Liss T, McFetridge A, Wu R, Cavallo D . Contingency management for smoking cessation: enhancing feasibility through use of immunoassay test strips measuring cotinine. Nicotine Tob Res. 2008; 10(9):1495-501. PMC: 3679884. DOI: 10.1080/14622200802323209. View

4.
. Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep. 2009; 58(44):1227-32. View

5.
Cooke F, Bullen C, Whittaker R, McRobbie H, Chen M, Walker N . Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008; 10(4):607-12. DOI: 10.1080/14622200801978680. View